World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
17823
World Ranking
18560
National Ranking
1680

Research.com Recognitions

  • 1996 - Fellow of the Royal Society of Edinburgh

Overview

John F. Smyth is affiliated with the University of Edinburgh in the United Kingdom. Their academic career includes recognition as a Fellow of the Royal Society of Edinburgh since 1996.

Details on Smyth's areas of research, publications, co-authors, and frequent publication venues are not available. No recent papers, book publications, or specific fields and subfields of study have been documented.

Although information regarding their main topics of work or collaborative network is unavailable, their fellowship status indicates a level of engagement with the scholarly community at the University of Edinburgh and in broader academic circles.

The lack of detailed publication or field data limits a comprehensive overview of their specific research contributions or thematic focus within their discipline.

Best Publications

  • The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans

    Kellie A. Charles;Hagen Kulbe;Robin Soper;Monica Escorcio-Correia

  • Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.

    A. Sulkes;J. Smyth;C. Sessa;L. Y. Dirix

  • Characterization and properties of nine human ovarian adenocarcinoma cell lines.

    Simon P. Langdon;Sandra S. Lawrie;Frances G. Hay;Mary M. Hawkes

  • WWOX: A candidate tumor suppressor gene involved in multiple tumor types

    A. J. W. Paige;K. J. Taylor;C. Taylor;S. G. Hillier

  • Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall.

    S. Prescott;K. James;T.B. Hargreave;G.D. Chisholm

  • Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial

    J F Smyth;A Bowman;T Perren;Peter M Wilkinson

  • The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

    J. M. S. Bartlett;S. P. Langdon;B. J. B. Simpson;M. Stewart

  • Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.

    Michael D Oberst;Michael D Johnson;Robert B Dickson;Chen-Yong Lin

  • OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.

    Grant C Sellar;Karen P Watt;Genevieve J Rabiasz;Euan A Stronach

  • Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer

    D J Boote;I F Dennis;P R Twentyman;R J Osborne

  • A prognostic model for ovarian cancer.

    T G Clark;M E Stewart;D G Altman;H Gabra

  • A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

    Hagen Kulbe;Probir Chakravarty;D. Andrew Leinster;Kellie A. Charles

  • Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients

    John F. Smyth;Charlie Gourley;Graeme Walker;Melanie J. MacKean

  • Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study

    D A Cameron;M C Cornbleet;R M Mackie;J A A Hunter

  • A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

    E. R. Brown;K. A. Charles;S. A. Hoare;R. L. Rye

  • Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

    Gi Ming Lai;Robert F. Ozols;John F. Smyth;Robert C. Young

  • Carcinosarcoma of the Ovary 19 Years of Prospective Data from a Single Center

    Ewan Brown;Moira Stewart;Tzyvia Rye;Awatif Al-Nafussi

  • Cutaneous malignant melanoma, Scotland, 1979-89

    R MacKie;T.C Aitchison;J.A.A Hunter;K Mclaren

  • Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen

    Amanda J M O’Donnell;Kenneth G Macleod;David J Burns;John F Smyth

  • Immunological Aspects of Cancer Chemotherapy

    Kenneth C. Calman;John F. Smyth;Martin H. N. Tattersall;Martin H. N. Tattersall

Frequent Co-Authors

Simon P. Langdon
Simon P. Langdon University of Edinburgh
Martin H.N. Tattersall
Martin H.N. Tattersall University of Sydney
William R. Miller
William R. Miller University of New Mexico
Kenneth G. MacLeod
Kenneth G. MacLeod University of Missouri
Frances R. Balkwill
Frances R. Balkwill Queen Mary University of London
Enrique Rozengurt
Enrique Rozengurt University of California, Los Angeles
David J. Porteous
David J. Porteous University of Edinburgh
Stan B. Kaye
Stan B. Kaye Royal Marsden NHS Foundation Trust
Robert E. Coleman
Robert E. Coleman University of Sheffield
Keith James
Keith James University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine in the USA doesn't always mean enrolling in traditional medical school. There are several related online degrees and career pathways that offer lucrative and rewarding options in healthcare.

For those with a non-nursing background interested in advanced nursing, direct entry msn programs for non-nursing majors online provide a fast-track to become a registered nurse and pursue graduate-level qualifications.

If you prefer to earn your nursing credential quickly, adn nursing programs offer a shorter time to licensure and can be more accessible than traditional BSN programs.

For those seeking less patient-focused roles, the growing field of health administration and insurance may appeal. Programs from accredited medical billing and coding schools online with financial aid can launch a medical office career quickly and affordably.

Entry requirements also vary. Some do you have to take a teas test for lpn options do not require standardized admission exams, making the application process easier for many students.

Exploring these alternative pathways can open doors to healthcare careers beyond traditional medicine, providing flexibility and a range of opportunities.

Best Scientists Citing John F. Smyth

Trending Scientists

Recently Published Articles